Pearl River Capital’s Regeneron Pharmaceuticals REGN Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-3,814	Closed	-$3.14M	–	599
2023 Q3	$3.14M	Sell	3,814 -3,019	-44%	-$2.37M	0.49%	50
2023 Q2	$4.91M	Buy	6,833 +3,960	+138%	+$3.05M	0.79%	17
2023 Q1	$2.36M	Sell	2,873 -46	-2%	-$34.7K	0.37%	76
2022 Q4	$2.11M	Sell	2,919 -724	-20%	-$534K	0.36%	80
2022 Q3	$2.51M	Sell	3,643 -1,715	-32%	-$1.08M	0.47%	53
2022 Q2	$3.17M	Buy	+5,358	New	+$3.48M	0.75%	24
2022 Q1	–	Sell	-3,420	Closed	-$2.16M	–	535
2021 Q4	$2.16M	Buy	+3,420	New	+$2.1M	0.58%	39
2021 Q2	–	Sell	-4,548	Closed	-$2.15M	–	548
2021 Q1	$2.15M	Buy	4,548 +1,112	+32%	+$541K	0.69%	35
2020 Q4	$1.66M	Buy	+3,436	New	+$1.85M	0.59%	36
2020 Q2	–	Sell	-156	Closed	-$76K	–	522
2020 Q1	$76K	Buy	+156	New	+$64.3K	0.15%	188
2019 Q3	–	Sell	-312	Closed	-$98K	–	503
2019 Q2	$98K	Buy	+312	New	+$104K	0.63%	75